Medical Director, Clinical Development, Genetics Medicine
Regeneron Pharmaceuticals
Summary
At Regeneron, we use science and innovation to develop life-changing medicines for people with serious diseases. We are seeking a Medical Director, Clinical Development to join our MASH/Metabolism team, supporting genetic medicine programs from First in Human through Phase 3. In this role, you will lead cross-functional study teams to shape clinical development strategy and ensure the scientific integrity of trials, while collaborating closely with discovery scientists, translational researchers, and regulatory colleagues.
Job description
When & where:
- Location: Tarrytown, NY
- Work model/flexibility: On-site four days per week
- Travel percentage: 10% to relevant conferences/congresses
Discover your role:
- Lead cross-functional teams to craft novel clinical development strategy for genetic medicines
- Partner with discovery and translational scientists to understand emerging genetic targets across MASH, metabolism, rare diseases, and other therapeutic areas
- Author and finalize protocols, amendments, monitoring plans, SAPs, and regulatory submissions
- Evaluate the benefits and risks of assigned therapeutic candidates to inform program decisions
- Oversee trial execution, including adverse event review and ongoing monitoring of patient health and data quality
- Ensure team compliance with FDA, EMA, ICH, and GCP guidelines
- Conduct literature reviews to identify development opportunities from mechanistic, pharmacological, and clinical perspectives
- Represent clinical science in communications and meetings with regulatory agencies
This role requires:
- M.D. degree (M.D./Ph.D. or prior research experience preferred)
- Board Certification/Eligibility in a relevant therapeutic area (Hepatology, Gastroenterology, Endocrinology, or Nephrology preferred)
- 2-3+ years of clinical practice or industry experience preferred
- Track record of success in clinical or scientific research settings
Requirements
- M.D. degree
- Board Certification/Eligibility in a relevant therapeutic area (Hepatology, Gastroenterology, Endocrinology, or Nephrology preferred)
- 2-3+ years of clinical practice or industry experience preferred
- Track record of success in clinical or scientific research settings
Benefits
- Annual bonuses
- Incentive plans
- Equity awards
- Pension or retirement benefits
- 401(k) company match
- Health and wellness programs
- Fitness centers
- Medical insurance
- Dental insurance
- Vision insurance
- Life insurance
- Disability insurance
- Paid time off
- Family support benefits
Company overview
Regeneron Pharmaceuticals is a leading American biotechnology company founded in 1988 and headquartered in Tarrytown, New York. The company specializes in inventing, developing, and commercializing life-transforming medicines for people with serious diseases. Regeneron is renowned for its innovative antibody technologies and has developed several groundbreaking therapies, including EYLEA® for retinal diseases, DUPIXENT® for inflammatory conditions, and the COVID-19 antibody cocktail REGEN-COV®. The company operates with a strong focus on research and development across multiple therapeutic areas including ophthalmology, oncology, cardiovascular diseases, and rare genetic disorders. Regeneron's proprietary VelocImmune® technology platform enables the rapid generation of fully human monoclonal antibodies. With over 15,000 employees globally and annual revenues exceeding $14 billion, Regeneron has established itself as a major force in the biotechnology industry, consistently ranking among the top-performing pharmaceutical companies and maintaining a robust pipeline of investigational therapies.